Renal UDP-glucuronosyltransferases and the glucuronidation of xenobiotics and endogenous mediators

References

• Anders, M. W. (1980). Metabolism of drugs by the kidney. Kidney Int 18:636–647.
   PubMed Web of Science ®Google Scholar
• Barbier, O., Lapointe, H., El-Alfy, M., Hum, D. W. (2000). Cellular localization of uridine diphosphoglucuronosyltransferase 2B enzymes in the human prostate by in situ hybridization and immunohistochemistry. J Clin Endocrinol Metab 85:4819–4826.
   PubMed Web of Science ®Google Scholar
• Beaulieu, M., Levesque, E., Hum, D. W., Belanger, A. (1996). Isolation and characterization of a novel cDNA encoding a human UDP-glucuronosyltransferase active on C19 steroids. J Biol Chem 271:22855–22862.
   PubMed Web of Science ®Google Scholar
• Beaulieu, M., Levesque, E., Hum, D. W., Belanger, A. (1998). Isolation and characterization of a human orphan UDP-glucuronosyltransferase, UGT2B11. Biochem Biophys Res Commun 248:44–50.
   PubMed Web of Science ®Google Scholar
• Bernard, O., Guillemette, C. (2004). The main role of UGT1A9 in the hepatic metabolism of mycophenolic acid and the effects of naturally occurring variants. Drug Metab Disp 32:775–778.
   PubMed Web of Science ®Google Scholar
• Bledsoe, T., Liddle, G. W., Riondel, A., Island, D. P., Bloomfield, D., Sinclair-Smith, B. (1966). Comparative fates of intravenously and orally administered aldosterone: evidence for extrahepatic formation of acid-hydrolyzable conjugate in man. J Clin Invest 45:264–269.
   PubMed Web of Science ®Google Scholar
• Bowalgaha, K., Elliot, D. J., Mackenzie, P. I., Knights, K. M., Swedmark, S., Miners, J. O. (2005). S-naproxen and desmethylnaproxen glucuronidation by human liver microsomes and recombinant human UDP-glucuronosyltransferase (UGT): role of UGT2B7 in the elimination of naproxen. Br J Clin Pharmacol 60:423–433.
   PubMed Web of Science ®Google Scholar
• Bowalgaha, K., Miners, J. O. (2001). The glucuronidation of mycophenolic acid by human liver, kidney, and jejunum microsomes. Br J Clin Pharmacol 52:605–609.
   PubMed Web of Science ®Google Scholar
• Botting, R. M. (2006). Cyclooxygenase: past, present, and future. A tribute to John R. Vane (1927–2004). J Therm Biol 31:208–219.
   Web of Science ®Google Scholar
• Brunelle, F. M., Verbeeck, R. K. (1996). Glucuronidation of diflunisal in liver and kidney microsomes of rat and man. Xenobiotica 26:123–131.
   PubMed Web of Science ®Google Scholar
• Capdevila, J.H, Falck, J.R, Harris, R.C. (2000). Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachidonate monooxygenase. J Lipid Res 41:163–181.
   PubMed Web of Science ®Google Scholar
• Cappiello, M., Giuliani, L., Pacifici, G. M. (1991). Distribution of UDP-glucuronosyltransferase and its endogenous substrate uridine 5’-diphosphoglucuronic acid in human tissues. Eur J Clin Pharmacol 41:345–350.
   PubMed Web of Science ®Google Scholar
• Chowdhury, J. R., Novikoff, P. M., Chowdhury, N. R., Novikoff, A. B. (1985). Distribution of UDP-glucuronosyltransferase in rat tissue. Proc Natl Acad Sci 82:2990–2994.
   PubMed Web of Science ®Google Scholar
• Coffman, B. L., Rios, G. R., King, C. D., Tephly, T. R. (1997). Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab Disp 25:1–4.
   PubMed Web of Science ®Google Scholar
• Coughtrie, M. W., Burchell, B., Bend, J. R. (1987). Purification and properties of rat kidney UDP-glucuronosyltransferase. Biochem Pharmacol 36:245–251.
   PubMed Web of Science ®Google Scholar
• Court, M. H., Duan, S. X., von Moltke, L. L., Greenblatt, D. J., Patten, C. J., Miners, J. O., et al. (2001). Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms. J Pharmacol Exp Ther 299:998–1006.
   PubMed Web of Science ®Google Scholar
• Court, M. H., Hazarika, S., Krishnaswamy, S., Finel, M., Williams, J. A. (2008). Novel polymorphic human UDP-glucuronosyltransferase 2A3: cloning, functional characterization of enzyme variants, comparative tissue expression, and gene induction. Mol Pharmacol 74:744–754.
   PubMed Web of Science ®Google Scholar
• Court, M. H., Krishnaswamy, S., Hao, Q., Duan, S. X., Patten, C. J., Von Moltke, L. L., et al. (2003). Evaluation of 3’-azido-3’deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism. Drug Metab Disp 31:1125–1133.
   PubMed Web of Science ®Google Scholar
• Elmamlouk, T. H., Mukhtar, H., Bend, J. R. (1981). The nuclear envelope as a site of glucuronosyltransferase in rat liver: properties of and effect of inducers on enzyme activity. J Pharmacol Exp Ther 219:27–34.
   PubMed Web of Science ®Google Scholar
• Fisher, M. B., Vanden Branden, M., Findlay, K., Burchell, B., Thummel, K. E., Hall, S. D., et al. (2000). Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bank. Pharmacogenetics 10:727–739.
   PubMedGoogle Scholar
• Funk, C. D. (2001). Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294:1871–1875.
   PubMed Web of Science ®Google Scholar
• Gaganis, P., Miners, J. O., Brennan, J. S., Thomas, A., Knights, K. M. (2007a). Human renal cortical and medullary UDP-glucuronosyltransferases (UGTs): immunohistochemical localization of UGT2B7 and UGT1A enzymes and kinetic characterization of S-naproxen glucuronidation. J Pharmacol Exp Ther 323:422–430.
   PubMed Web of Science ®Google Scholar
• Gaganis, P., Miners, J. O., Knights, K. M. (2007b). Glucuronidation of fenamates: kinetic studies using human kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UGT) 1A9 and 2B7. Biochem Pharmacol 73:1683–1691.
   PubMed Web of Science ®Google Scholar
• Gaiser, B. K., Lockley, D. J., Staines, A. G., Baarnhielm, C., Burchell, B. (2003). Almokalant glucuronidation in human liver and kidney microsomes: evidence for the involvement of UGT1A9 and 2B7. Xenobiotica 33:1073–1083.
   PubMed Web of Science ®Google Scholar
• Gambro, G., Perazella, M. A. (2003). Adverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors. J Int Med 253:643–652.
   PubMed Web of Science ®Google Scholar
• Girard, C., Barbier, O., Veilleux, G., El-Afy, M., Belanger, A. (2003). Human uridine diphosphate-glucuronosyltransferase UGT2B7 conjugates mineralocorticoid and glucocorticoid metabolites. Endocrinology 144:2659–2668.
   PubMed Web of Science ®Google Scholar
• Gray, P. A., Park, G. R., Cockshott, I. D., Douglas, E. J., Shuker, B., Simons, P. J. (1992). Propofol metabolism in man during the anhepatic and reperfusion phases of liver transplantation. Xenobiotica 22:105–114.
   PubMed Web of Science ®Google Scholar
• Green, M. D., King, C. D., Mojarrabi, B., Mackenzie, P. I., Tephly, T. R. (1998). Glucuronidation of amines and other xenobiotics catalysed by expressed human UDP-glucuronosyltransferase 1A3. Drug Metab Disp 26:507–512.
   PubMed Web of Science ®Google Scholar
• Hiraoka, H., Yamamoto, K., Miyoshi, S., Morita, T., Nakamura, K., Kadoi, Y., et al. (2005). Kidneys contribute to the extrahepatic clearance of propofol in humans, but not lungs and brain. Br J Clin Pharmacol 60:172–182.
   PubMedGoogle Scholar
• Hjelle, J. T., Hazelton, G. A., Klaassen, C. D., Hjelle, J. J. (1986). Glucuronidation and sulfation in rabbit kidney. J Pharmacol Exp Ther 236:150–156.
   PubMed Web of Science ®Google Scholar
• Hobkirk, R., Nilsen, M. (1971). Metabolism of 17β-estradiol to 17β-estradiol-3-glucosiduronate and 17β-estradiol-17-glucosiduronate by the normal human female. J Clin Endocrinol 32:779–785.
   Web of Science ®Google Scholar
• Hobkirk, R., Green, R. N., Nilsen, M., Jennings, B. A. (1973). Formation of estrogen glucosiduronates by human kidney homogenates. Can J Biochem 52:9–14.
   Google Scholar
• Hook, G. E. R., Haseman, J. K., Lucier, J. W. (1975). Induction and suppression of hepatic and extrahepatic microsomal foreign-compound metabolizing enzyme systems by 2,3,7,8-tetrachlorodibeno-p-dioxin. Chem Biol Interact 10:199–214.
   PubMed Web of Science ®Google Scholar
• Imig, J. D. (2000). Eicosanoid regulation of renal vasculature. Am J Physiol 279:F965–F981.
   Google Scholar
• Itaaho, K., Mackenzie, P. I., Ikushiro, S. I., Miners, J. O., Finel, M. (2008). The configuration of the 17-hydroxy group variably influences the glucuronidation of β-estradiol and epiestradiol by human UDP-glucuronosyltransferases. Drug Metab Dispos 36:2307–2315.
   PubMed Web of Science ®Google Scholar
• Jin, C. J., Miners, J. O., Lillywhite, K. J., Mackenzie, P. I. (1993). Complementary deoxyribonucleic cloning and expression of a human liver uridine diphosphate glucuronosyltransferase glucuronidating carboxylic acid containing drugs. J Pharmacol Exp Ther 264:475–479.
   PubMed Web of Science ®Google Scholar
• Jude, A. R., Little, J. M., Freeman, J. P., Evans, J. E., Radominska-Pandya, A., Grant, D. F. (2000). Linoleic acid diols are novel substrates for human UDP-glucuronosyltransferases. Arch Biochem Biophys 380:294–302.
   PubMed Web of Science ®Google Scholar
• Jude, A. R., Little, J. M., Bull, A. W., Podgorski, I., Radominska-Pandya, A. (2001a). 13-hydroxy- and 13-oxooctadecadienoic acids: novel substrates for human UDP-glucuronosyltransferases. Drug Metab Dispos 29:652–655.
   PubMed Web of Science ®Google Scholar
• Jude, A. R., Little, J. M., Czernik, P. J., Tephly, T. R., Grant, D. F., Radominska-Pandya, A. (2001b). Glucuronidation of linoleic acid diols by human microsomal and recombinant UDP-glucuronosyltransferases: identification of UGT2B7 as the major isoform involved. Arch Biochem Biophys 389:176–186.
   PubMed Web of Science ®Google Scholar
• Kerdpin, O., Knights, K. M., Elliot, D. J., Miners, J. O. (2008). In vitro characterisation of human renal and hepatic frusemide glucuronidation and identification of the UDP-glucuronosyltransferase enzymes involved in this pathway. Biochem Pharmacol 76:249–257.
   PubMed Web of Science ®Google Scholar
• Knights, K. M., Tsoutsikos, P., Miners, J. O. (2005). Novel mechanisms of nonsteroidal anti-inflammatory drug-induced renal toxicity. Exp Opin Drug Metab Toxicol 1:399–408.
   PubMedGoogle Scholar
• Knights, K. M., Winner, L. K., Elliot, D. J., Bowalgaha, K, Miners, J. O. (2009). Aldosterone glucuronidation by human liver and kidney microsomes and recombinant UDP-glucuronosyltransferases: inhibition by NSAIDs. Br J Clin Pharmacol (in press).
   PubMed Web of Science ®Google Scholar
• Koster, A. S., Schirmer, G., Bock, K. W. (1986). Immunochemical and functional characterization of UDP-glucuronosyltransferases from rat liver, intestine, and kidney. Biochem Pharmacol 35:3971–3975.
   PubMed Web of Science ®Google Scholar
• Lepine, J., Bernard, O., Plante, M., Tetu, B., Pelletier, G., Labrie, F., et al. (2004). Specificity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methoxyestrogen metabolites by human uridine diphospho-glucuronosyltransferases expressed in endometrium. J Clin Endocrin Metab 89:5222–5232.
   PubMed Web of Science ®Google Scholar
• Levesque, E., Beaulieu, M., Green, M. D., Tephly, T. R., Belanger, A., Hum, D. W. (1997). Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics 7:317–325.
   PubMedGoogle Scholar
• Levesque, E., Beaulieu, M., Hum, D. W., Belanger, A. (1999). Characterization and substrate specificity of UGT2B4(E458): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics 9:207–216.
   PubMedGoogle Scholar
• Litterst, C. L., Mimnaugh, E. G., Gram, T. E. (1977). Comparative alterations in extrahepatic drug metabolism by factors known to affect hepatic activity. Biochem Pharmacol 26:749–755.
   PubMed Web of Science ®Google Scholar
• Little, J. M., Kurkela, M., Sonka, J., Jantti, S., Ketola, R., Bratton, S., et al. (2004). Glucuronidation of oxidised fatty acids and prostaglandins B1 and E2 by human hepatic and recombinant UDP-glucuronosyltransferases (UGT). J Lipid Res 45:1694–1703.
   PubMed Web of Science ®Google Scholar
• Lohr, J. W., Willsky, G. R., Acara, M. A. (1998). Renal drug metabolism. Pharmacolog Rev 50:107–141.
   PubMed Web of Science ®Google Scholar
• Mackenzie, P. I. (2000). Identification of uridine diphosphate glucuronosyltransferases involved in the metabolism and clearance of mycophenolic acid. Ther Drug Monit 22:10–13.
   PubMed Web of Science ®Google Scholar
• Mackenzie, P. I., Bock, K. W., Burchell, B., Guillemette, C., Ikushiro, S., Iyanagi, T., et al. (2005). Nomenclature update for the mammalian UDP-glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genom 15:677–685.
   PubMed Web of Science ®Google Scholar
• Mano, Y., Usui, T., Kamimura, H. (2006). Identification of human UDP-glucuronosyltransferase responsible for the glucuronidation of niflumic acid in human liver. Pharmacet Res 23:1502–1508.
   Google Scholar
• Mazoit, J. X., Sandhouk, P., Scherrmann, J-M., Roche, A. (1990). Extrahepatic metabolism of morphine occurs in humans. Clin Pharmacol Ther 48:613–618.
   PubMed Web of Science ®Google Scholar
• McGurk, K. A., Brierley, C. H., Burchell, B. (1998). Drug glucuronidation by human renal UDP-glucuronosyltransferases. Biochem Pharmacol 55:1005–1012.
   PubMed Web of Science ®Google Scholar
• McGurk, K. A., Remmel, R. P., Hosagrahara, V. P., Tosh. D., Burchell, B. (1996). Reactivity of mefenamic acid 1-o-acyl glucuronide with proteins in vitro and ex vivo. Drug Metab Dispos 24:842–849.
   PubMed Web of Science ®Google Scholar
• Mellor, J. D., Hobkirk, R. (1975). In vitro synthesis of estrogen glucuronides and sulfates by human renal tissue. Can J Biochem 53:779–783.
   PubMedGoogle Scholar
• Miners, J. O, Knights, K. M, Houston, J. B, Mackenzie, P. I. (2006). In vitro–in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: pitfalls and promises. Biochem Pharmacol 71:1531–1539.
   PubMed Web of Science ®Google Scholar
• Miners, J. O., Mackenzie, P. I., Knights, K. M. (2009). The prediction of drug glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro–in vivo extrapolation of drug clearance and drug-drug interaction potential. Drug Metab Rev (in press).
   Web of Science ®Google Scholar
• Miners, J. O., Lillywhite, K. J., Matthews, A. P., Jones, M. E., Birkett, D. J. (1988). Kinetic and inhibitor studies of 4-methylumbelliferone and 1-naphthol glucuronidation in human liver microsomes. Biochem Pharmacol 37:665–671.
   PubMed Web of Science ®Google Scholar
• Miners, J. O., Mackenzie, P. I. (1991). Drug glucuronidation in humans. Pharmacol Ther 51:347–369.
   PubMed Web of Science ®Google Scholar
• Miners, J. O., Smith, P. A., Sorich, M. J., McKinnon, R. A., Mackenzie, P. I. (2004). Predicting human drug glucuronidation parameters: application if in vitro and in silico modeling approaches. Annu Rev Pharmacol Toxicol 44:1–25.
   PubMed Web of Science ®Google Scholar
• Mojarrabi, B., Mackenzie, P. I. (1997). The human UDP-glucuronosyltransferase UGT1A10 glucuronidates mycophenolic acid. Biochem Biophys Res Commun 238:775–778.
   PubMed Web of Science ®Google Scholar
• Mojarrabi, B., Mackenzie, P. I. (1998). Characterization of two UDP-glucuronosyltransferases that are predominantly expressed in human colon. Biochem Biophys Res Comm 247:704–709.
   PubMed Web of Science ®Google Scholar
• Moran, J. H., Weise, R., Schnellmann, R. G., Freeman, J. P., Grant, D. F. (1997). Cytotoxicity of linoleic acid diols to renal proximal tubular cells. Toxicol Appl Pharmacol 146:53–59.
   PubMed Web of Science ®Google Scholar
• Moran, J. H., Nowak, G., Grant, D. F. (2001). Analysis of the toxic effects of linoleic acid, 12,13-cis-epoxyoctadecenoic acid, and 12,13-dihydroxyoctadecenoic acid in rabbit renal cortical mitochondria. Toxicol Appl Pharmacol 172:150–161.
   PubMed Web of Science ®Google Scholar
• Murray, G. I., Burke, M. D. (1995). Immunohistochemistry of drug-metabolizing enzymes. Biochem Pharmacol 50:895–903.
   PubMed Web of Science ®Google Scholar
• Mutlib, A. E., Goosen, T. C., Bauman, J. N., Williams, J. A., Kulkarni, S., Kostrubsky, S. (2006). Kinetics of acetaminophen glucuronidation by UDP-glucuronosyltransferases 1A1, 1A6, 1A9, and 2B15. Potential implications in acetaminophen-induced hepatotoxicity. Chem Res Toxicol 19:701–709.
   PubMed Web of Science ®Google Scholar
• Nakamura, A., Nakajima, M., Yamanaka, H., Fujiwara, R., Yokoi, T. (2008). Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines. Drug Metab Disp 36:1461–1464.
   PubMed Web of Science ®Google Scholar
• Nebert, D. W. (1994). Drug-metabolizing enzymes in ligand-modulated transcription. Biochem Pharmacol 47:25–37.
   PubMed Web of Science ®Google Scholar
• Nie, D., Che, M., Grignon, D., Tang, K., Honn, K. V. (2001). Role of eicosanoids in prostate cancer progression. Cancer Metast 20:195–206.
   PubMed Web of Science ®Google Scholar
• Nishiyama, T., Kobori, T., Arai, K., Ogura, K., Ohnuma, T., Ishii, K., et al. (2006). Identification of human UDP-glucuronosyltransferase isoform(s) responsible for the C-glucuronidation of phenylbutazone. Arch Biochem Biophys 454:72–79.
   PubMed Web of Science ®Google Scholar
• Ohno, S., Kawana, K., Nakajin, S. (2008). Contribution of UDP-glucuronosyltransferase 1A1 and 1A8 to morphine-6-glucuronidation and its kinetic properties. Drug Metab Disp 36:688–694.
   PubMed Web of Science ®Google Scholar
• Ohno, S., Nakajin, S. (2009). Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction. Drug Metab Disp 37:32–40.
   PubMed Web of Science ®Google Scholar
• Pacifici, G. M., Viani, A., Franchi, M., Gervasi, P. G., Longo, V., Di Simplicio, P., et al. (1989). Profile of drug-metabolizing enzymes in the cortex and medulla of the human kidney. Pharmacology 39:299–308.
   PubMed Web of Science ®Google Scholar
• Peters, W. H. M., Allebes, W. A., Jansen, P. L. M., Poels, L. G., Capel, P. J. A. (1987). Characterization and tissue specificity of a monoclonal antibody against human uridine 5’-diphosphate-glucuronosyltransferase. Gastroenterology 93:162–169.
   PubMed Web of Science ®Google Scholar
• Picard, N., Ratanasavanh, D., Premaud, A., Le Meur, Y., Marquet, P. (2005). Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism. Drug Metab Dispos 33:139–146.
   PubMed Web of Science ®Google Scholar
• Prakash, C., Zhang, J. Y., Falck, J. R., Chauhan, K., Blair, I. A. (1992). 20-hydroxyeicosatetraenoic acid is excreted as a glucuronide conjugate in human urine. Biochem Biophys Res Comm 185:728–733.
   PubMed Web of Science ®Google Scholar
• Pritchard, M., Fournel-Gigleux, S., Siest, G., Mackenzie, P., Magdalou, J. (1994). A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyses the glucuronidation of morphine, phenols, and carboxylic acids. Mol Pharmacol 45:42–50.
   PubMed Web of Science ®Google Scholar
• Radominska-Pandya, A., Pokrovskaya, I. D., Xu, J., Little, J. M., Jude, A. R., Kurten, R. C., et al. (2002). Nuclear UDP-glucuronosyltransferases: identification of UGT2B7 and UGT1A6 in human liver nuclear membranes. Arch Biochem Biophys 399:37–48.
   PubMed Web of Science ®Google Scholar
• Raftogianis, R., Creveling. C., Weinshilboum, R., Weisz, J. (2000). Estrogen metabolism by conjugation. J Natl. Cancer Inst Monogr 27:113–124.
   Google Scholar
• Raoof, A. A., van Obbergh, L. J., de Ville de Goyet, J., Verbeeck, R. K. (1996). Extrahepatic glucuronidation of propofol in man: possible contribution of gut wall and kidney. Eur J Clin Pharmacol 50:91–96.
   PubMed Web of Science ®Google Scholar
• Roman, R. J. (2002). P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82:131–185.
   PubMed Web of Science ®Google Scholar
• Rowland, A., Gaganis, P., Elliot, D. J., Mackenzie, P. I., Knights, K. M., Miners, J. O. (2007). Binding of inhibitory fatty acids is responsible for the enhancement of UDP-glucuronosyltransferase 2B7 activity by albumin: implications for in vitro–in vivo extrapolation. J Pharmacol Ther 321:137–147.
   PubMed Web of Science ®Google Scholar
• Rowland, A., Knights, K. M., Mackenzie, P. I., Miners, J. O. (2008). The albumin effect and drug glucuronidation: bovine serum albumin and fatty-acid free human serum albumin enhance the glucuronidation of UDP-glucuronosyltransferase (UGT) 1A9 substrates but not UGT1A1 and UGT1A6 activities. Drug Metab Disp 36:1056–1062.
   PubMed Web of Science ®Google Scholar
• Ruidera, E., Irazu, C. E., Rajagopalan, P. R., Orak, J. K., Fitts, C. T., Singh, I. (1988). Fatty acid metabolism in renal ischemia. Lipids 23:882–884.
   PubMed Web of Science ®Google Scholar
• Rush, G. F., Hook, J. B. (1984) Characteristics of renal UDP-glucuronyltransferase. Life Sci 35:145–153.
   PubMed Web of Science ®Google Scholar
• Sakaguchi, K., Green, M., Stock, N., Reger, T. S., Zunic, J., King, C. (2004). Glucuronidation of carboxylic acid containing compounds by UDP-glucuronosyltransferase isoforms. Arch Biochem Biophys 424:219–225.
   PubMed Web of Science ®Google Scholar
• Schaaf, G. J., de Groene, E. M., Maas, R. F., Commandeur, J. N. M., Fink-Gremmels, J. (2001). Characterization of biotransformation in primary rat proximal tubular cells. Chemico Biol Interact 134:167–190.
   PubMed Web of Science ®Google Scholar
• Simmons, D. L., Botting, R. M., Hla, T. (2004). Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 56:387–437.
   PubMed Web of Science ®Google Scholar
• Soars, M. G., Riley, R. J., Findlay, K. A. B., Coffey., M. J., Burchell, B. (2001). Evidence for significant differences in microsomal drug glucuronidation by canine and human liver and kidney. Drug Metab Disp 29:121–126.
   PubMed Web of Science ®Google Scholar
• Soars, M. G., Burchell, B., Riley, R. J. (2002). In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance. J Pharmacol Exp Ther 301:382–390.
   PubMed Web of Science ®Google Scholar
• Sonka, J., Little, J., Samokyszyn, V., Radominska-Pandya, A. (2002). Glucuronidation of arachidonic acid, 20-hydroxy-eicosatetraenoic acid, and prostaglandin E2 by human hepatic and intestinal UDP-glucuronosyltransferases and recombinant UGT2B7. Drug Metab Rev 34(Suppl 1):194.
   Google Scholar
• Staines, A. G., Coughtrie, M. W. H., Burchell, B. (2004). N-glucuronidation of carbamazepine in human tissues is mediated by UGT2B7. J Pharmacol Exp Ther 311:1131–1137.
   PubMed Web of Science ®Google Scholar
• Stevenson, I. H., Dutton, G. J. (1962). Glucuronide synthesis in kidney and gastrointestinal tract. Biochem J 82:330–340.
   PubMed Web of Science ®Google Scholar
• Stone, A. N., Mackenzie, P. I., Galetin, A., Houston, J. B., Miners, J. O. (2003). Isoform selectivity and kinetics of morphine 3- and 6-glucuronidation by human UDP-glucuronosyltransferases: evidence for atypical glucuronidation kinetics by UGT2B7. Drug Metab Disp 31:1086–1089.
   PubMed Web of Science ®Google Scholar
• Sutherland, L., Ebner, T., Burchell, B. (1993). The expression of UDP-glucuronosyltransferases of the UGT1 family in human liver and kidney and in response to drugs. Biochem Pharmacol 45:295–301.
   PubMed Web of Science ®Google Scholar
• Tsoutsikos, P., Miners, J. O., Stapleton, A., Thomas, A., Sallustio, B. C., Knights, K. M. (2004). Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGTs): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7. Biochem Pharmacol 67:191–199.
   PubMed Web of Science ®Google Scholar
• Turgeon, D., Carrier, J. S., Levesque, E., Hum, D. W., Belanger, A. (2001). Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members. Endocrinology 142:778–787.
   PubMed Web of Science ®Google Scholar
• Turgeon, D., Chouinard, S., Belanger, P., Picard, S., Labbe, J. F., Borgeat, P., et al. (2003). Glucuronidation of arachidonic and linoleic acid metabolites by human UDP-glucuronosyltransferases. J Lipid Res 44:1182–1191.
   PubMed Web of Science ®Google Scholar
• Uchaipichat, V., Mackenzie, P. I., Guo, X-H., Gardner-Stephen, D., Galetin, A., Houston, J. B., et al. (2004). Human UDP-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid. Drug Metab Disp 34:413–423.
   Google Scholar
• Uchaipichat, V., Winner, L. K., Mackenzie, P. I., Elliot, D. J., Williams, J. A., Miners, J. O. (2006). Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidation. Br J Clin Pharmacol 61:427–439.
   PubMed Web of Science ®Google Scholar
• Vietri, M., Pietrabissa, A., Mosca, F., Pacifici, G. M. (2000). Mycophenolic acid glucuronidation and its inhibition by nonsteroidal anti-inflammatory drugs in human liver and kidney. Eur J Clin Pharmacol 56:659–664.
   PubMed Web of Science ®Google Scholar
• Wheelan, P., Hankin, J. A., Bilir, B., Guenette, D., Murphy, R. C. (1999). Metabolic transformations of leukotriene B4 in primary cultures of human hepatocytes. J Pharmacol Exp Ther 288:326–334.
   PubMed Web of Science ®Google Scholar
• Yue, Q. Y., Odar-Cederlof, I., Svensson, J. O., Sawe, J. (1988). Glucuronidation of morphine in human kidney microsomes. Pharmacol Toxicol 63:337–341.
   PubMedGoogle Scholar
• Yue, Q. Y., von Bahr, C., Odar-Cederlof, I., Sawe, J. (1990). Glucuronidation of codeine and morphine in human liver and kidney microsomes: effect of inhibitors. Pharmacol Toxicol 66:221–226.
   PubMedGoogle Scholar
• Zemski Berry, K. A., Borgea, P., Gosselin, J., Flamand, L., Murphy, R. C. (2003). Urinary metabolites of leukotriene B4 in the human subject. J Biol Chem 278:24449–24460.
   PubMed Web of Science ®Google Scholar